Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS ...

Women with epithelial ovarian cancer who happened to be taking nonselective beta-blockers for hypertension survived longer than those who were not taking the drugs, according to a large multicenter ...

Not sure about you, but nervous energy comes at me like a bat out of hell. And, of course, it’s always at the literal worst moments. Big job interview? My heart races like it’s at the Olympics.

Imagine you're about to give a presentation to a room full of people.

Two systematic reviews revealed very low-certainty evidence on outcomes for people with gender dysphoria. (HealthDay News) — There is considerable uncertainty regarding the effects of puberty blockers ...